Literature DB >> 15018545

Synthesis and characterization of ionic liquids incorporating the nitrile functionality.

Dongbin Zhao1, Zhaofu Fei, Rosario Scopelliti, Paul J Dyson.   

Abstract

A series of imidazolium salts with the nitrile functional group attached to the alkyl side chain, viz. [CnCNmim][X] (where CnCNmim is the 1-alkylnitrile-3-methylimidazolium cation and Cn= (CH2)(n), n = 1-4; X = Cl, PF(6), and BF(4)) and [C3CNdmim][X] (where CnCNdmim is the 1-alkylnitrile-2,3-dimethylimidazolium cation and C(n) = (CH2)(n), n = 3; X = Cl, PF(6), and BF(4)), have been prepared and characterized using spectroscopic methods. The majority of the nitrile-functionalized imidazolium salts can be classed as ionic liquids since they melt below 100 degrees C. Four of the imidazolium salts have been characterized in the solid state using single-crystal X-ray diffraction analysis to reveal an extensive series of hydrogen bonds between H atoms on the cation and the anion. The relationship between the solid-state structure and the melting point is discussed. Key physical properties (density, viscosity, and solubility in common solvents) of the low melting ionic liquid have been determined and are compared with those of the related 1-alkyl-3-methylimidazolium and 1-alkyl-2,3-dimethylimidazolium ionic liquids. It was envisaged that these ionic liquids could act as both solvent and ligand for catalyzed reactions, and this application is demonstrated in hydrogenation reactions, which show that retention of the catalyst in the ionic liquid during product extraction is extremely high.

Entities:  

Year:  2004        PMID: 15018545     DOI: 10.1021/ic034801p

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Tris(1-ethyl-3-methyl-imidazolium) hexa-bromidoeuropate(III).

Authors:  Michael Pellens; Ben Thijs; Kristof Van Hecke; Luc Van Meervelt; Koen Binnemans; Peter Nockemann
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.